Favourites   Have ideas?  Sign in / Register

Positive:   Cannabis ↓9.43   Farm ↓8.18   Disease: Infectious ↓7.58 «See more»   Disease: Neurology/Alzheimer/Parkinson's ↑8.24   Animals ↑45.43   Pets ↑45.43

Negative:   Bad infrastructure  ↑2.21


Biotechnology segment

ACOR Acorda Therapeutics, Inc. - Common Stock up -26.09% 26.09 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology


Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK
+ My List
APTO Aptose Biosciences, Inc. - Common Shares -1.79% -1.79% 0 + Biotechnology

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock 5% down 18.12% -13.12 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
BNTC Benitec Biopharma Inc. - Common Stock -10.74% -10.74% 0 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
BNTX BioNTech SE - American Depositary Shares -1.57% down 8.99% -10.56 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock 2.21% down 7.75% -5.54 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DARE Dare Bioscience, Inc. - Common Stock -1.74% down 10.78% -12.52 + Biotechnology, Healthcare, Women Health


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $DARE Dare Bioscience, Inc. https://t.co/iSB0Q2Ucpd
+ My List
ENTX Entera Bio Ltd. - Ordinary Shares 6.31% 6.31% 0 + Country: Israel, Biotechnology, Pharmaceutical


Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd. https://t.co/dws8IKVGAV #healthcare
+ My List
ENTXW Entera Bio Ltd. - Warrant 0 + Country: Israel, Biotechnology, Pharmaceutical

+ My List
FBIO Fortress Biotech, Inc. - Common Stock -6.73% up -8.65% 1.92 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock 0.52% 0.52% 0 + Medicine, Biotechnology, Biopharma

+ My List
FLDM Fluidigm Corporation - Common Stock -7.02% -7.02% 0 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270
+ My List
FRLN Freeline Therapeutics Holdings plc - ADSs -7.84% -7.84% 0 + Medicine, Biotechnology, Gene and cell

+ My List
GLYC GlycoMimetics, Inc. - Common Stock up -8% 8 + Biotechnology, Medicine, Disease: Leukemia

+ My List
IGMS IGM Biosciences, Inc. - Common Stock -0.42% down 8.83% -9.25 + Biotechnology, Gene and cell, Medicine


Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number
+ My List
IMNM Immunome, Inc. - Common Stock 2.9% down 12.24% -9.34 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMRN Immuron Limited - American Depositary Shares 5.86% 5.86% 0 + Biotechnology, Country: Australia, Biopharma, Medicine


Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited https://t.co/xsrBOQcQ0a
+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock 1.15% down 8.46% -7.31 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
KIN Kindred Biosciences, Inc. - Common Stock 45.43% down 45.74% -0.31 + Animals, Biopharma, Biotechnology, Medicine, Pets


Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924
+ My List
LRMR Larimar Therapeutics, Inc. - Common Stock -0.78% up -7.91% 7.13 + Medicine, Gene and cell, Biotechnology

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock -7.58% -7.58% 0 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MCRB Seres Therapeutics, Inc. - Common Stock 5.41% up -10.35% 15.76 + Medicine, Microbiome, Biotechnology


Last highlighted: #MCRB SEC report: Seres Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Seres Therapeutics, Inc. -- SEC File Number 211137957
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock -1.03% down 9.91% -10.94 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -4.32% down 10.42% -14.74 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
OMER Omeros Corporation - Common Stock 3.56% down 17.06% -13.5 + Biopharma, Biotechnology, Medicine


Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number
+ My List
ONCR Oncorus, Inc. - Common Stock 14.75% down 17.31% -2.56 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ORGS Orgenesis Inc. - Common Stock -8.26% -8.26% 0 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 3.28% down 11.36% -8.08 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares -6% up -7% 1 + Medicine, Biotechnology, Disease: Eye , RNA

+ My List
QRVO Qorvo, Inc. - Common Stock 5% down 7.08% -2.08 + Semiconductor, Biotechnology, Diagnosing, IoT, 5G, Mobile, Network Infrastructure, Equipment

+ My List
RGNX REGENXBIO Inc. - Common Stock -7.44% -7.44% 0 + Gene and cell, Biotechnology, Medicine

+ My List
RKDA Arcadia Biosciences, Inc. - Common Stock 3.13% down 7.69% -4.56 + Agritech, Biotechnology


Last highlighted: #RKDA SEC report: Arcadia Biosciences, Inc. [Amend] Current report, item 9.01
SEC Filing Form 8-K/A filed by Arcadia Biosciences, Inc. -- SEC File Number 211136758
+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock -1.63% -1.63% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine


Last highlighted: $RLMD 📜 SEC Form 10-Q filed by Relmada Therapeutics, Inc. https://t.co/CGB5BcamVJ 30s delayed. This insight appeared in real-time at 🚆 https://t.co/TvhaBDQJ0C 🚆
+ My List
RVMD Revolution Medicines, Inc. - Common Stock -28.74% -28.74% 0 + Cancer fight, Medicine, Biotechnology

+ My List
SELB Selecta Biosciences, Inc. - Common Stock up -9.71% 9.71 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SNES SenesTech, Inc. - Common Stock 0 + Biotechnology, Agritech


Last highlighted: $SNES SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/6t4UWwGDlL
+ My List
TWST Twist Bioscience Corporation - Common Stock 0.45% up -7.15% 7.6 + Biotechnology, RNA, Medicine


Last highlighted: #TWST SEC report: Twist Bioscience Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Twist Bioscience Corp -- SEC File Number
+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares -3.91% up -18.83% 14.92 + Medicine, Biotechnology, Life Sciences

+ My List
XOMA XOMA Corporation - Common Stock up -7.03% 7.03 + Biotechnology, Medicine, Acquisitions/Investing

+ My List
YTEN Yield10 Bioscience, Inc. - Common Stock 3.72% down 18.75% -15.03 + Biotechnology, Agritech, Food

+ My List
AGFY Agrify Corporation - Common Stock -8.18% -8.18% 0 + Biotechnology, Cannabis, Farm, Agritech

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.68% -10.68% 0 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share 6.15% down 7.45% -1.3 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
GBS GBS Inc. - Common Stock -6% up -8% 2 + Medicine, Biotechnology

+ My List
IDBA IDEX Biometrics ASA - American Depositary Shares 3.75% down 7.74% -3.99 + Technology, Security, Biotechnology, Fingerprint

+ My List
LGVN Longeveron Inc. - common stock 16.48% 16.48% 0 + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's

+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock up -19.83% 19.83 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock 1.71% down 11.42% -9.71 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
VRDN Viridian Therapeutics, Inc. - Common Stock 0.00% 0 + Disease: Eye , Medicine, Biotechnology


Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm) 📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment) https://t.co/Ot2kOEW3mb #VRDN #8KA #ViridianTherapeutics #News
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.